3-{3-[{[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride (1:1)(CAS: 148849-67-6)

3-{3-[{[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride (1:1), with CAS number 148849-67-6, is a complex organic compound containing a 3-benzazepin-2-one ring and a bicyclo[4.2.0]octa-1,3,5-triene structure. It is a hydrochloride salt, which enhances its solubility and stability, making it suitable for pharmaceutical applications. The compound is characterized by its molecular complexity and potential biological activity.

This compound is primarily used in pharmaceutical research for its potential pharmacological properties, particularly in the development of drugs targeting central nervous system disorders. It may also find applications in medicinal chemistry as a structural analog or intermediate in the synthesis of bioactive compounds. Its use in industrial or food sectors is limited due to its specialized nature and potential for biological activity.

Safety information for this compound is limited, but as it is a pharmaceutical intermediate, it should be handled with appropriate precautions. Users should wear personal protective equipment (PPE) such as gloves, goggles, and lab coats. It is important to follow safety guidelines for chemical handling, especially in laboratory settings. Long-term toxicity data is not widely available, so caution is advised during use and disposal.

This compound should be stored in a cool, dry, and dark place, ideally at 2-8°C. It should be kept in a sealed, airtight container to prevent moisture absorption and maintain its chemical integrity. Avoid exposure to light and air to ensure stability. Proper storage is essential to preserve its potency and safety for use in research or pharmaceutical applications.